Free account + included starter software — credential review typically takes 1–2 business days. See how it works
NDC 18657-0117-04

Hyaluronidase 150 [USP'U]/mL INJECTION, SOLUTION

Antares Pharma, Inc.

In Stock at Premier Pharma
NDC
18657-0117-04
Generic Name
Hyaluronidase
Brand Name
HYLENEX Recombinant
Strength
150 [USP'U]/mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Package Size
—
Labeler
Antares Pharma, Inc.

FDA Drug Information

Indications & Usage

1. Indications and Usage HYLENEX recombinant is an endoglycosidase indicated as an adjuvant in subcutaneous fluid administration for achieving hydration ( 1.1 ) to increase the dispersion and absorption of other injected drugs ( 1.2 ) in subcutaneous urography for improving resorption of radiopaque agents ( 1.3 ) 1.1. Subcutaneous Fluid Administration HYLENEX recombinant is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2. Dispersion and Absorption of In…

Source: FDA. For professional use only. Not a substitute for prescribing information.

View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Hyaluronidase Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
More from Antares Pharma, Inc. →
Browse all Antares Pharma, Inc. products available at wholesale

Wholesale and compliance resources

DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.

Order NDC 18657-0117-04 at Wholesale

Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).

Create AccountNDC Lookup